Avacta Group Plc (AIM:AVCT)
London · Delayed Price · Currency is GBP · Price in GBX 65.00
+0.80 (1.25%)
Oct 15, 2026, 4:40 PM GMT
Avacta Group Market Cap
Avacta Group has a market cap or net worth of 316.41 million as of October 15, 2026. It is the 16,053rd most valuable company in the world and the 342nd biggest in the United Kingdom. Its market cap has increased by 10.78% in one year.
Market Cap
316.41M
Enterprise Value
316.00M
Revenue
113.00K
Global Rank
Country Rank
#342 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since September 29, 2006, Avacta Group's market cap has increased from 37.46M to 316.41M, an increase of 744.67%. That is a compound annual growth rate of 11.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 316.41M | 25.86% |
| Dec 31, 2025 | 251.39M | 37.41% |
| Dec 31, 2024 | 182.95M | -43.88% |
| Dec 29, 2023 | 325.99M | 9.26% |
| Dec 30, 2022 | 298.35M | -5.82% |
| Dec 31, 2021 | 316.78M | 11.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oxford Nanopore Technologies | 2.12B |
| Genus | 1.51B |
| Oxford Biomedica | 653.61M |
| PureTech Health | 267.25M |
| Scancell Holdings | 113.34M |
| Bioventix | 94.57M |
| 4basebio | 87.40M |
| Faron Pharmaceuticals Oy | 75.39M |